Diseases & Conditions Related News
Coeliac disease linked to bacterial exposure, new study suggests
Bacterial exposure has been identified as a potential environmental risk factor in developing coeliac disease, a hereditary autoimmune-like condition that affects around 1 in...
Breakthrough research offers new hope to lupus patients
A ‘life-changing’ potential new drug could be available to lupus patients in the future thanks to ‘breakthrough’ research.
The results of the TULIP II study...
Getting the right dose: taking a good look at medicinal cannabis products
Leafcann Group Pty Ltd showcase the variety of delivery methods available and the importance of GMP certified products.
In today’s environment there is an abundance...
New tool reveals DNA structures that influence disease
Disruption of certain DNA structures – called topologically associating domains, or – TADs – is linked with the development of disease, including some cancers.
With...
Want to hear the latest developments regarding Tetra’s hepatocellular carcinoma drug?
Responsible for 80% of primary malignant liver tumours in adults, hepatocellular carcinoma is a common form of liver cancer – but did you know...
Prediabetes: an emerging health threat can lead to type 2 diabetes
A new study has shown that nearly one in five adolescents aged 12-18 years, and one in five young adults aged 19-34 years, are...
Measuring stressed cells to understand the development of disease
When cells are stressed, they initiate a complex and precisely regulated response to prevent permanent damage.
Researchers from Goethe University have developed a new protoeomics...
Young people with IBD more likely to develop serious infections
A first of its kind study analysed almost 2,700 IBD patients to understand the respective roles of IBD activity and drugs in promoting systemic...
Let’s look beyond the New Modalities Ecosystem
What do you know about the unique multidiscipline collaboration combining high level academic knowledge with drug discovery and development?
In 2018, Orion Corporation, together with...
Climate change: risks to health are growing but health funding isn’t
A new WHO report has highlighted the lack of support for health sectors in the face of climate change.
The report, from the World Health...
Breakthrough discovery reveals how memories are coded in the brain
NUS researchers have made a breakthrough in the field of cognitive computational neuroscience, by discovering a key aspect of how the brain encodes short-term...
First steps towards a vaccine for pancreatic cancer achieved
Researchers have developed a personalised vaccine system that could delay the onset of pancreatic cancer.
The study, conducted by researchers from Queen Mary University of...
Imaging study provides insights on functional neurological disorder
Individuals with functional neurological disorder (FND) have symptoms not explained by traditional neurological conditions.
New research led by investigators at Massachusetts General Hospital (MGH) and...
NHS England urge eligible people to get free flu vaccine
The primary school flu vaccination programme is resuming following temporary delay of nasal spray vaccine from the manufacturer.
The NHS and Public Health England (PHE)...
Is there a link between inflammation and cognition?
An estimated 12m UK citizens have a chronic medical condition, and many of them report severe mental fatigue that they characterise as 'sluggishness' or...
The only alternative to antibiotics for animals is disease prevention
Dr Olivier Espeisse, of AnimalhealthEurope, discusses how the alternative to antibiotics for animals is prevention of disease.
Tackling drug resistance is often treated like the...
Age-related macular degeneration to affect 77 million Europeans by 2050
The leading cause of irreversible blindness and severely impaired eyesight – age-related macular degeneration (AMD) – is expected to affect 77 million Europeans by...
Could lenalidomide delay the onset of myeloma-related bone, organ damage?
According to the Eastern Cooperative Oncology Group, lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.
Published in the...
Oral cholera vaccine: IVI awarded $4.5 million grant to increase accessibility
The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to increase accessibility of oral cholera...
Canadian Vaping Association responds to BC’s first potential vaping illness
The Canadian Vaping Association (CVA) has responded to the first potentially vaping related illness in DC.
The Canadian Vaping Association is deeply concerned about the...
